Stay updated on Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial

Sign up to get notified when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record now presents details of the completed Phase 3 oteseconazole study for recurrent vulvovaginal candidiasis, including its design, eligibility criteria, locations, outcomes, and study documents, instead of an access-denied message.
    Difference
    50%
    Check dated 2026-11-08T13:23:47.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T14:10:51.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a transition.
    Difference
    1%
    Check dated 2026-10-25T18:12:13.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:23:44.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T22:21:47.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The study page now shows a new Revision: v3.7.0 tag, signaling an update to the record. Several older documents and items (e.g., Statistical Analysis Plan, Study Protocol, PDFs, and related metadata) were removed from the history on the page.
    Difference
    17%
    Check dated 2026-09-20T20:41:55.000Z thumbnail image

Stay in the know with updates to Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.